Kenmare Resources Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 featured strong shipments and operational progress despite softer production due to plant upgrades. Market conditions for ilmenite remained weak, but zircon prices improved and new product ZrTi saw robust demand. Constructive regulatory negotiations and stable customer relationships support a positive outlook.
-
A leading titanium minerals producer in Mozambique is navigating a market trough with cost controls and capital discipline, while ramping up production and strengthening community and government partnerships. Long-term prospects remain strong, with a focus on sustainability and value creation.
-
Negotiations with the Mozambican government over the Implementation Agreement have intensified after the Tax Authority imposed higher royalties and revoked IFZ status, creating financial uncertainty. The company is accruing the higher royalty but seeks a negotiated solution, with arbitration as a last resort. Only the royalty increase has been implemented so far.
-
Guidance for 2026 prioritizes shipments and cash generation over production, targeting a 15% increase in shipments and lower operating costs. Major capital projects are concluding, with a focus on cost control, community investment, and ongoing negotiations for improved fiscal terms in Mozambique.
Fiscal Year 2025
-
2025 saw a sharp revenue and EBITDA decline due to weak ilmenite and zircon markets, major CapEx, and a $301M impairment, prompting cost cuts, dividend suspension, and a focus on liquidity. 2026 guidance includes lower CapEx, cost reductions, and increased shipments, with ongoing market and regulatory risks.
-
Production and shipments were down in Q3 due to the WCPA upgrade and vessel maintenance, but the major capital project is on track and over 80% complete. Market conditions remain soft, with price recovery expected in late 2026, while the company maintains strong cash generation, ongoing shareholder returns, and a focus on sustainability.
-
Solid H1 2025 results with stable operations, a slight revenue uptick, and a 30% EBITDA margin, despite higher costs and a $100M impairment. CapEx for the WCPA project is on track, and the company maintains guidance while navigating market softness and ongoing agreement negotiations.
-
Stable operations and strong safety marked H1 2025, with flat revenue, a 30% EBITDA margin, and a $100M non-cash impairment due to lower pricing outlook and higher royalties. Major capital projects are on track, and the interim dividend was maintained despite market softness and ongoing agreement negotiations.
Fiscal Year 2024
-
Revenue and EBITDA declined year-over-year due to softer prices, but strong production and cost control supported a 40% EBITDA margin. Major capital projects are on track, with robust demand and steady outlook for 2025. Dividend payout remains at the upper end of policy.
-
Revenue and shipments declined in H1 2024, but strong cash flow and a robust balance sheet support ongoing investment and dividends. Production and shipments are set to rebound in H2, with stable pricing and strong market demand expected.